Addex Therapeutics (ADXN) Research & Development: 2022-2025
Historic Research & Development for Addex Therapeutics (ADXN) over the last 3 years, with Jun 2025 value amounting to -$283,195.
- Addex Therapeutics' Research & Development rose 24.52% to -$283,195 in Q2 2025 from the same period last year, while for Jun 2025 it was $1.2 million, marking a year-over-year decrease of 8.72%. This contributed to the annual value of $971,090 for FY2024, which is 26.51% down from last year.
- According to the latest figures from Q2 2025, Addex Therapeutics' Research & Development is -$283,195, which was down 63.15% from -$173,584 recorded in Q1 2025.
- Over the past 5 years, Addex Therapeutics' Research & Development peaked at $21.3 million during Q4 2022, and registered a low of -$6.0 million during Q2 2022.
- Its 3-year average for Research & Development is $11,748, with a median of -$278,465 in 2023.
- The largest annual percentage gain for Addex Therapeutics' Research & Development in the last 5 years was 93.23% (2023), contrasted with its biggest fall of 88.23% (2023).
- Addex Therapeutics' Research & Development (Quarterly) stood at $21.3 million in 2022, then plummeted by 88.23% to $2.5 million in 2023, then decreased by 25.19% to $1.9 million in 2024, then grew by 24.52% to -$283,195 in 2025.
- Its Research & Development stands at -$283,195 for Q2 2025, versus -$173,584 for Q1 2025 and $1.9 million for Q4 2024.